Skip to content
TrendOpen UK

The Zimbabwean Government Declines ‘Unbalanced’ US Health Aid Package Due to Information Fears

Medical aid illustration
The proposed US funding would have supported initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a significant US healthcare agreement worth 367 million US dollars (272 million pounds) over five years over the United States' insistence on sensitive biological samples.

This rejection came to light after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".

A government representative has since clarified that the United States was requesting health data for research and profit but was not willing to share the benefits from any future medical innovations.

"We are forced to start the difficult and regrettable process of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for continued talks to secure a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a comparable case in Kenya, where a high court blocked a related health funding agreement following concerns were raised about the security of Kenyans' medical information.

After resuming office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.

As per reports, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Deal

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.

"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our population if a future health crisis arise."

National Interest and International Frameworks

Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending frameworks previously established through the international health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.

"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."

These objections over the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome continued discussions with our US partners on how future collaboration could be designed in a manner that respects the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but urged that talks need to persist given that a large portion of the country's HIV programmes depended on external financing.

"Where technical issues arise, including those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it added.

The situation highlights the continuing debate between accepting crucial international aid and protecting a country's data in an increasingly interconnected world.

About the author

Richard Dominguez

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and startup ecosystems across Europe.

TrendOpen UK

Type to search articles.